Middle East and Africa Neuromodulation Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology (External (Non-Invasive) Neuromodulation, and Internal Neuromodulation); Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Obsessive-Compulsive Disorder, and Migraine); End User (Hospitals, Clinics, and Home Healthcare) and Geography

No. of Pages: 113    |    Report Code: TIPRE00016325    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East and Africa Neuromodulation Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East and Africa Neuromodulation Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East and Africa Neuromodulation Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growing Developments in Neuromodulation Technology
5.2 Market Opportunities
  • 5.2.1 Rising Demand for Neurostimulation Devices to Treat Chronic Pain
5.3 Future Trends
  • 5.3.1 Technological Advancements
5.4 Impact of Drivers and Restraints

6. Middle East and Africa Neuromodulation Market Regional Analysis

6.1 Middle East and Africa Neuromodulation Market Overview
6.2 Middle East and Africa Neuromodulation Market Revenue 2017-2027 (US$ Million)
6.3 Middle East and Africa Neuromodulation Market Forecast Analysis

7. Middle East and Africa Neuromodulation Market Analysis – by Technology

7.1 External Neuromodulation
  • 7.1.1 Overview
  • 7.1.2 External Neuromodulation: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Internal Neuromodulation
  • 7.2.1 Overview
  • 7.2.2 Internal Neuromodulation: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East and Africa Neuromodulation Market Analysis – by Application

8.1 Chronic Pain Management
  • 8.1.1 Overview
  • 8.1.2 Chronic Pain Management: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Failed Back Syndrome
  • 8.2.1 Overview
  • 8.2.2 Failed Back Syndrome: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Epilepsy
  • 8.3.1 Overview
  • 8.3.2 Epilepsy: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Tremor
  • 8.4.1 Overview
  • 8.4.2 Tremor: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Incontinence
  • 8.5.1 Overview
  • 8.5.2 Incontinence: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Depression
  • 8.6.1 Overview
  • 8.6.2 Depression: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Dystonia
  • 8.7.1 Overview
  • 8.7.2 Dystonia: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.8 Gastroparesis
  • 8.8.1 Overview
  • 8.8.2 Gastroparesis: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.9 Parkinson's Disease
  • 8.9.1 Overview
  • 8.9.2 Parkinson's Disease: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.10 Obsessive-Compulsive Disorder
  • 8.10.1 Overview
  • 8.10.2 Obsessive-Compulsive Disorder: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.11 Migraine
  • 8.11.1 Overview
  • 8.11.2 Migraine: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9. Middle East and Africa Neuromodulation Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Migraine: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Migraine: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Home Healthcare
  • 9.3.1 Overview
  • 9.3.2 Migraine: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

10. Middle East and Africa Neuromodulation Market – Middle East and Africa Analysis

10.1 Middle East and Africa
  • 10.1.1 Middle East and Africa Neuromodulation Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 Middle East and Africa Neuromodulation Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 South Africa: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 South Africa: Middle East and Africa Neuromodulation Market Breakdown, by Technology
    • 10.1.1.1.2 South Africa: Middle East and Africa Neuromodulation Market Breakdown, by Application
    • 10.1.1.1.3 South Africa: Middle East and Africa Neuromodulation Market Breakdown, by End User
  • 10.1.1.2 Saudi Arabia: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Saudi Arabia: Middle East and Africa Neuromodulation Market Breakdown, by Technology
    • 10.1.1.2.2 Saudi Arabia: Middle East and Africa Neuromodulation Market Breakdown, by Application
    • 10.1.1.2.3 Saudi Arabia: Middle East and Africa Neuromodulation Market Breakdown, by End User
  • 10.1.1.3 UAE: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 UAE: Middle East and Africa Neuromodulation Market Breakdown, by Technology
    • 10.1.1.3.2 UAE: Middle East and Africa Neuromodulation Market Breakdown, by Application
    • 10.1.1.3.3 UAE: Middle East and Africa Neuromodulation Market Breakdown, by End User
  • 10.1.1.4 Rest of Middle East and Africa: Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.4.1 Rest of Middle East and Africa: Middle East and Africa Neuromodulation Market Breakdown, by Technology
    • 10.1.1.4.2 Rest of Middle East and Africa: Middle East and Africa Neuromodulation Market Breakdown, by Application
    • 10.1.1.4.3 Rest of Middle East and Africa: Middle East and Africa Neuromodulation Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Middle East and Africa Neuromodulation Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Boston Scientific Corporation
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Medtronic
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 NeuroPace, Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 NeuroSigma, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 NEVRO CORP.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Synapse Biomedical Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Soterix Medical Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Integer Holdings Corporation
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Magstim
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - M Market

The List of Companies - Middle East and Africa Neuromodulation Market

  1. Abbott
  2. Boston Scientific Corporation
  3. Medtronic
  4. NeuroPace, Inc.
  5. NeuroSigma, Inc.
  6. NEVRO CORP.
  7. Synapse Biomedical Inc.
  8. Soterix Medical Inc
  9. Integer Holdings Corporation
  10. Magstim

 

middle-east-and-africa-neuromodulation-market